2023-07-18 00:33:16 ET
- Neptune Wellness Solutions press release ( NASDAQ: NEPT ): Q4 GAAP EPS of -$2.23 misses by $1.95 .
- Revenue of $12.15 million (+5.4% Y/Y) beats by $1.5 million .
- Adjusted EBITDA profit (loss) for fiscal year 2023 was -$39.7 million compared to an Adjusted EBITDA profit (loss) of -$53.3 million for the fiscal year 2022, an improvement of 26%.
- Raymond P. Silcock, Chief Financial Officer of Neptune added, "As well as growing our key focus business areas of Sprout and Biodroga, Neptune is focused on further reducing corporate costs, managing expenses and improving its liquidity position into fiscal 2024. We are focused on further optimizing the supply chain for Sprout, and we have restructured production planning with $2.6 million in cost savings for the remainder of fiscal 2023 expected."
For further details see:
Neptune Wellness Solutions GAAP EPS of -$2.23 misses by $1.95, revenue of $12.15M beats by $1.5M